Long-term survival of dialysis patients after coronary bypass grafting

Lawrence J Dacey1, Jean Y Liu, John H Braxton

  • 1Department of Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire 03756-0001, USA. lawrence.j.dacey@dartmouth.edu

Insights

Patients with renal failure undergoing coronary artery bypass grafting (CABG) face significantly higher long-term mortality. Those with co-existing diabetes or peripheral vascular disease (PVD) are at especially high risk.

Area of Science:

  • Cardiovascular Surgery
  • Nephrology
  • Outcomes Research

Background:

  • Increasing frequency of coronary artery bypass grafting (CABG) in dialysis patients.
  • Limited understanding of long-term mortality impact of preoperative renal failure post-CABG.

Purpose of the Study:

  • To investigate the long-term survival outcomes for patients with dialysis-dependent renal failure undergoing CABG.
  • To identify specific risk factors influencing mortality in this patient population.

Main Methods:

  • Prospective regional cohort study of 15,574 isolated CABG patients (1992-1997).
  • Linkage to National Death Index for mortality assessment.
  • Calculation of five-year survival and adjusted hazard ratios.

Main Results:

  • Renal failure present in 1.8% of patients; 67.8% had diabetes or peripheral vascular disease (PVD).
  • Five-year survival was 55.8% for all renal failure patients vs. 83.5% for non-renal failure patients.
  • Renal failure patients with diabetes or PVD had a >4-fold increased risk of death compared to those without renal failure.

Conclusions:

  • Renal failure is a significant predictor of reduced long-term survival after CABG, even after adjusting for other risk factors.
  • Co-morbidity of renal failure with diabetes or PVD dramatically increases mortality risk in CABG patients.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...